Precipitation casting of drug-loaded microporous PCL matrices: incorporation of progesterone by co-dissolution

H.-I. Chang, M.R. Williamson, Yvonne Perrie, Allan G.A. Coombes

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Microporous, poly(ε-caprolactone) (PCL) matrices were loaded with progesterone by precipitation casting using co-solutions of PCL and progesterone in acetone. Progesterone loadings up to 32% w/w were readily achieved by increasing the drug content of the starting PCL solution. The kinetics of steroid release in PBS at 37 °C over 10 days could be described effectively by a diffusional release model although the Korsmeyer–Peppas model indicated the involvement of multiple release phenomena. The diffusion rate constant (D) increased from 8 to 24 μg/mg matrix/day0.5 as the drug loading increased from 3.6 to 12.4% w/w. A total cumulative release of 75%–95% indicates the high efficiency of steroid delivery. Increasing the matrix density from 0.22 to 0.39 g/cm3, by increasing the starting PCL solution concentration, was less effective in changing drug release kinetics. Retention of anti-proliferative activity of released steroid was confirmed using cultures of breast cancer epithelial (MCF-7) cells. Progesterone released from PCL matrices into PBS at 37 °C over 14 days retarded the growth of MCF-7 cells by a factor of at least 3.5 compared with progesterone-free controls. These findings recommend further investigation of precipitation-cast PCL matrices for delivery of bioactive molecules such as anti-proliferative agents from implanted, inserted or topical devices.
LanguageEnglish
Pages263-272
Number of pages10
JournalJournal of Controlled Release
Volume106
Issue number3
DOIs
Publication statusPublished - 1 Sep 2005

Fingerprint

Progesterone
Pharmaceutical Preparations
Steroids
MCF-7 Cells
Acetone
Pharmacokinetics
Breast Neoplasms
Equipment and Supplies
Growth

Keywords

  • poly(ε-caprolactone)
  • microporous
  • matrix
  • progesterone
  • MCF-7 cells

Cite this

@article{491a01aeb7274792b91c7f3090e8c439,
title = "Precipitation casting of drug-loaded microporous PCL matrices: incorporation of progesterone by co-dissolution",
abstract = "Microporous, poly(ε-caprolactone) (PCL) matrices were loaded with progesterone by precipitation casting using co-solutions of PCL and progesterone in acetone. Progesterone loadings up to 32{\%} w/w were readily achieved by increasing the drug content of the starting PCL solution. The kinetics of steroid release in PBS at 37 °C over 10 days could be described effectively by a diffusional release model although the Korsmeyer–Peppas model indicated the involvement of multiple release phenomena. The diffusion rate constant (D) increased from 8 to 24 μg/mg matrix/day0.5 as the drug loading increased from 3.6 to 12.4{\%} w/w. A total cumulative release of 75{\%}–95{\%} indicates the high efficiency of steroid delivery. Increasing the matrix density from 0.22 to 0.39 g/cm3, by increasing the starting PCL solution concentration, was less effective in changing drug release kinetics. Retention of anti-proliferative activity of released steroid was confirmed using cultures of breast cancer epithelial (MCF-7) cells. Progesterone released from PCL matrices into PBS at 37 °C over 14 days retarded the growth of MCF-7 cells by a factor of at least 3.5 compared with progesterone-free controls. These findings recommend further investigation of precipitation-cast PCL matrices for delivery of bioactive molecules such as anti-proliferative agents from implanted, inserted or topical devices.",
keywords = "poly(ε-caprolactone), microporous, matrix, progesterone, MCF-7 cells",
author = "H.-I. Chang and M.R. Williamson and Yvonne Perrie and Coombes, {Allan G.A.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1016/j.jconrel.2005.05.013",
language = "English",
volume = "106",
pages = "263--272",
journal = "Journal of Controlled Release",
issn = "0168-3659",
number = "3",

}

Precipitation casting of drug-loaded microporous PCL matrices : incorporation of progesterone by co-dissolution. / Chang, H.-I.; Williamson, M.R.; Perrie, Yvonne; Coombes, Allan G.A.

In: Journal of Controlled Release, Vol. 106, No. 3, 01.09.2005, p. 263-272.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Precipitation casting of drug-loaded microporous PCL matrices

T2 - Journal of Controlled Release

AU - Chang, H.-I.

AU - Williamson, M.R.

AU - Perrie, Yvonne

AU - Coombes, Allan G.A.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Microporous, poly(ε-caprolactone) (PCL) matrices were loaded with progesterone by precipitation casting using co-solutions of PCL and progesterone in acetone. Progesterone loadings up to 32% w/w were readily achieved by increasing the drug content of the starting PCL solution. The kinetics of steroid release in PBS at 37 °C over 10 days could be described effectively by a diffusional release model although the Korsmeyer–Peppas model indicated the involvement of multiple release phenomena. The diffusion rate constant (D) increased from 8 to 24 μg/mg matrix/day0.5 as the drug loading increased from 3.6 to 12.4% w/w. A total cumulative release of 75%–95% indicates the high efficiency of steroid delivery. Increasing the matrix density from 0.22 to 0.39 g/cm3, by increasing the starting PCL solution concentration, was less effective in changing drug release kinetics. Retention of anti-proliferative activity of released steroid was confirmed using cultures of breast cancer epithelial (MCF-7) cells. Progesterone released from PCL matrices into PBS at 37 °C over 14 days retarded the growth of MCF-7 cells by a factor of at least 3.5 compared with progesterone-free controls. These findings recommend further investigation of precipitation-cast PCL matrices for delivery of bioactive molecules such as anti-proliferative agents from implanted, inserted or topical devices.

AB - Microporous, poly(ε-caprolactone) (PCL) matrices were loaded with progesterone by precipitation casting using co-solutions of PCL and progesterone in acetone. Progesterone loadings up to 32% w/w were readily achieved by increasing the drug content of the starting PCL solution. The kinetics of steroid release in PBS at 37 °C over 10 days could be described effectively by a diffusional release model although the Korsmeyer–Peppas model indicated the involvement of multiple release phenomena. The diffusion rate constant (D) increased from 8 to 24 μg/mg matrix/day0.5 as the drug loading increased from 3.6 to 12.4% w/w. A total cumulative release of 75%–95% indicates the high efficiency of steroid delivery. Increasing the matrix density from 0.22 to 0.39 g/cm3, by increasing the starting PCL solution concentration, was less effective in changing drug release kinetics. Retention of anti-proliferative activity of released steroid was confirmed using cultures of breast cancer epithelial (MCF-7) cells. Progesterone released from PCL matrices into PBS at 37 °C over 14 days retarded the growth of MCF-7 cells by a factor of at least 3.5 compared with progesterone-free controls. These findings recommend further investigation of precipitation-cast PCL matrices for delivery of bioactive molecules such as anti-proliferative agents from implanted, inserted or topical devices.

KW - poly(ε-caprolactone)

KW - microporous

KW - matrix

KW - progesterone

KW - MCF-7 cells

UR - http://www.sciencedirect.com/science/article/pii/S0168365905002294

U2 - 10.1016/j.jconrel.2005.05.013

DO - 10.1016/j.jconrel.2005.05.013

M3 - Article

VL - 106

SP - 263

EP - 272

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -